Q2 2020 Holdings
Filed 2020-08-13 | 222 holdings | $303.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $62.5M | 233,599 | 20.6% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $52.4M | 533,725 | 17.3% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $30.3M | 245,362 | 10.0% |
| Boston Scientific Corp.(BSX) | Common | 101137107 | $22.6M | 644,935 | 7.5% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $18.6M | 125,867 | 6.2% |
| Centene Corp.(CNC) | Common | 15135B101 | $18.3M | 288,194 | 6.0% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $14.1M | 74,984 | 4.7% |
| Acadia Pharmaceuticals Inc.(ACAD) | Common | 004225108 | $12.2M | 250,743 | 4.0% |
| argenx SE(ARGX) | Sponsored ADR | 04016X101 | $10.1M | 44,977 | 3.3% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $10.0M | 186,964 | 3.3% |
| Allogene Therapeutics, Inc.(ALLO) | Common | 019770106 | $9.3M | 216,069 | 3.1% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $8.5M | 57,482 | 2.8% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $4.2M | 607,698 | 1.4% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $3.6M | 203,103 | 1.2% |
| Acadia Healthcare Company, Inc.(ACHC) | Common | 00404A109 | $3.3M | 131,200 | 1.1% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $3.2M | 18,467 | 1.1% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $3.2M | 74,186 | 1.1% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $2.8M | 10,041 | 0.9% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $2.6M | 31,591 | 0.9% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $2.2M | 118,412 | 0.7% |
| Cellectis(CLLS) | Sponsored ADR | 15117K103 | $2.0M | 110,147 | 0.6% |
| Addus HomeCare Corp.(ADUS) | Common | 006739106 | $1.5M | 15,969 | 0.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $1.5M | 90,788 | 0.5% |
| BridgeBio Pharma, Inc.(BBIO) | Common | 10806X102 | $1.3M | 39,228 | 0.4% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $354.0K | 117,735 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $144.3K | 611,962 | 0.0% |
| Vertex Pharmaceuticals Inc.(VRTX) | Common | 92532F100 | $138.6K | 477,330 | 0.0% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $121.6K | 1,581,026 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $117.2K | 187,935 | 0.0% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $116.7K | 830,031 | 0.0% |
| Celldex Therapeutics, Inc.(CLDX) | Common | 15117B202 | $92.0K | 7,053 | 0.0% |
| Unitedhealth Group Inc.(UNH) | Common | 91324P102 | $82.6K | 280,151 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $79.5K | 214,651 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $75.1K | 971,496 | 0.0% |
| Bristol-Myers Squibb Co.(BMY) | Common | 110122108 | $57.5K | 977,505 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $54.2K | 1,656,548 | 0.0% |
| CVS Health Corp.(CVS) | Common | 126650100 | $46.8K | 719,620 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $44.5K | 486,250 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $43.6K | 475,489 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $43.2K | 384,709 | 0.0% |
| Seattle Genetics, Inc. | Common | 812578102 | $40.9K | 240,559 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $38.4K | 106,025 | 0.0% |
| Eli Lilly and Co.(LLY) | Common | 532457108 | $34.0K | 206,837 | 0.0% |
| Incyte Corp.(INCY) | Common | 45337C102 | $33.8K | 325,053 | 0.0% |
| Moderna, Inc.(MRNA) | Common | 60770K107 | $31.6K | 492,506 | 0.0% |
| Stryker Corp.(SYK) | Common | 863667101 | $29.6K | 164,230 | 0.0% |
| Danaher Corp.(DHR) | Common | 235851102 | $28.2K | 159,352 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $25.2K | 206,150 | 0.0% |
| Horizon Therapeutics plc | Shares | G46188101 | $22.8K | 410,153 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $22.5K | 140,129 | 0.0% |